Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PER977 for reversal of unfractionated heparin anticoagulation
NCT02206087Phase 2Completed
- Start
- Jun 2014
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ciraparantag in heparin-induced thrombocytopenia (HIT). Started Jun 2014; status: completed.
02
Drugs
ciraparantag
03
Conditions
heparin-induced thrombocytopenia (HIT)
Beyond the preview
Go deeper on NCT02206087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02206087.